Researcher profile

Brian Tom

Brian Tom contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Trust snapshot

Quick read

Trust 13 - UnverifiedVerification L1Unclaimed author
2works
0followers
2topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

2 published item(s)

preprint2022arXiv

DeepJoint: Robust Survival Modelling Under Clinical Presence Shift

Observational data in medicine arise as a result of the complex interaction between patients and the healthcare system. The sampling process is often highly irregular and itself constitutes an informative process. When using such data to develop prediction models, this phenomenon is often ignored, leading to sub-optimal performance and generalisability of models when practices evolve. We propose a multi-task recurrent neural network which models three clinical presence dimensions -- namely the longitudinal, the inter-observation and the missingness processes -- in parallel to the survival outcome. On a prediction task using MIMIC III laboratory tests, explicit modelling of these three processes showed improved performance in comparison to state-of-the-art predictive models (C-index at 1 day horizon: 0.878). More importantly, the proposed approach was more robust to change in the clinical presence setting, demonstrated by performance comparison between patients admitted on weekdays and weekends. This analysis demonstrates the importance of studying and leveraging clinical presence to improve performance and create more transportable clinical models.

preprint2022arXiv

Latent class mixed modelling for phenotypic stratification of primary biliary cholangitis patients on first line treatment

In patients with primary biliary cholangitis (PBC), the serum liver biochemistry measured during treatment with ursodeoxycholic acid (the UDCA response) accurately predicts long-term outcome. In this study we sought to use liver biochemistry, and in particular alkaline phosphatase (ALP), as a surrogate marker of disease activity, for phenotypic stratification in PBC using a computational modelling approach. Our aim here was to identify distinct disease subgroups of patients with distinct disease trajectories. Methods: We used longitudinal ALP results from 1,601 PBC patients on first line treatment with UDCA, and applied latent class mixed modelling (LCMM), to identify distinct phenotypic subgroups, each with distinct disease trajectories, and risks of end stage liver disease (ESLD). Results: We identified four well discriminated phenotypic subgroups within our PBC cohort, each with distinct disease trajectories.